NO20073787L - Nye pyrimidin-nukleosidforbindelser eller dets salt - Google Patents
Nye pyrimidin-nukleosidforbindelser eller dets saltInfo
- Publication number
- NO20073787L NO20073787L NO20073787A NO20073787A NO20073787L NO 20073787 L NO20073787 L NO 20073787L NO 20073787 A NO20073787 A NO 20073787A NO 20073787 A NO20073787 A NO 20073787A NO 20073787 L NO20073787 L NO 20073787L
- Authority
- NO
- Norway
- Prior art keywords
- group
- pyrimidine nucleoside
- nucleoside compounds
- alkyl group
- salt
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000002718 pyrimidine nucleoside Substances 0.000 title abstract 4
- 150000003839 salts Chemical class 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000006165 cyclic alkyl group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005023278 | 2005-01-31 | ||
| PCT/JP2006/301483 WO2006080509A1 (ja) | 2005-01-31 | 2006-01-30 | 新規ピリミジンヌクレオシド化合物又はその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073787L true NO20073787L (no) | 2007-09-27 |
Family
ID=36740526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073787A NO20073787L (no) | 2005-01-31 | 2007-07-20 | Nye pyrimidin-nukleosidforbindelser eller dets salt |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7825103B2 (ko) |
| EP (1) | EP1845102A4 (ko) |
| JP (1) | JP4966186B2 (ko) |
| KR (1) | KR20070103012A (ko) |
| CN (1) | CN101111509B (ko) |
| AU (1) | AU2006209422B2 (ko) |
| BR (1) | BRPI0607287A2 (ko) |
| CA (1) | CA2596060A1 (ko) |
| IL (1) | IL184779A0 (ko) |
| MY (1) | MY142304A (ko) |
| NO (1) | NO20073787L (ko) |
| NZ (1) | NZ560252A (ko) |
| RU (1) | RU2395517C2 (ko) |
| TW (1) | TW200637870A (ko) |
| WO (1) | WO2006080509A1 (ko) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2045256A4 (en) * | 2006-07-21 | 2009-09-02 | Taiho Pharmaceutical Co Ltd | 2'CYANOPYRIMIDINE NUCLEOSIDE COMPOUND |
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| US8759508B2 (en) | 2007-05-18 | 2014-06-24 | Ge Healthcare Dharmacon, Inc. | Chromophoric silyl protecting groups and their use in the chemical synthesis of oligonucleotides |
| CN101787066B (zh) * | 2009-01-23 | 2013-07-31 | 高峰 | 阿糖胞苷衍生物及其在抗癌抗肿瘤中的用途 |
| RU2732572C2 (ru) | 2016-05-31 | 2020-09-21 | Тайхо Фармасьютикал Ко., Лтд. | Сульфонамидное соединение или его соль |
| US10889555B2 (en) | 2016-05-31 | 2021-01-12 | Taiho Pharmaceutical Co., Ltd. | Sulfonamide compound or salt thereof |
| WO2018230479A1 (ja) * | 2017-06-13 | 2018-12-20 | 大原薬品工業株式会社 | ヌクレオシド系抗がん剤又は抗ウィルス剤の５'位シリルエーテル誘導体 |
| MA51228A (fr) * | 2017-11-29 | 2020-10-07 | Taiho Pharmaceutical Co Ltd | Agent antitumoral |
| ES2969901T3 (es) * | 2017-11-29 | 2024-05-23 | Taiho Pharmaceutical Co Ltd | Cocristal de ácido benzoico y compuesto de sulfonamida para el tratamiento de tumores |
| KR20190065139A (ko) * | 2017-12-01 | 2019-06-11 | 압타바이오 주식회사 | 혈액암 치료제 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE92499T1 (de) | 1984-12-04 | 1993-08-15 | Lilly Co Eli | Tumorbehandlung bei saeugetieren. |
| ZA859008B (en) * | 1984-12-04 | 1987-07-29 | Lilly Co Eli | The treatment of tumors in mammals |
| KR920002143B1 (ko) * | 1988-07-11 | 1992-03-12 | 다이호 야꾸힝고오교 가부시끼가이샤 | 5-치환 우리딘 유도체 및 그의 제조 중간체 |
| JP2559917B2 (ja) * | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
| JP2664837B2 (ja) * | 1991-06-07 | 1997-10-22 | 三井東圧化学株式会社 | トリフルオロチミジン誘導体、その製造法およびそれを有効成分とする制ガン剤 |
| FI105556B (fi) * | 1991-09-30 | 2000-09-15 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta |
| JPH07179491A (ja) | 1993-12-22 | 1995-07-18 | Sankyo Co Ltd | ５’−ホスファチジルピリミジンヌクレオチド誘導体 |
| JP2003113197A (ja) * | 2001-10-09 | 2003-04-18 | Mitsui Chemicals Inc | シチジンヌクレオシド誘導体の製造法 |
| JP4235182B2 (ja) | 2003-05-23 | 2009-03-11 | 富士通株式会社 | 光磁気記録媒体および光磁気記録媒体の製造方法並びに光磁気記録媒体駆動装置 |
-
2006
- 2006-01-27 MY MYPI20060419A patent/MY142304A/en unknown
- 2006-01-27 TW TW095103566A patent/TW200637870A/zh unknown
- 2006-01-30 RU RU2007132737/04A patent/RU2395517C2/ru not_active IP Right Cessation
- 2006-01-30 US US11/815,149 patent/US7825103B2/en not_active Expired - Fee Related
- 2006-01-30 BR BRPI0607287-9A patent/BRPI0607287A2/pt not_active IP Right Cessation
- 2006-01-30 EP EP06712626A patent/EP1845102A4/en not_active Withdrawn
- 2006-01-30 KR KR1020077017448A patent/KR20070103012A/ko not_active Application Discontinuation
- 2006-01-30 AU AU2006209422A patent/AU2006209422B2/en not_active Ceased
- 2006-01-30 NZ NZ560252A patent/NZ560252A/en not_active IP Right Cessation
- 2006-01-30 JP JP2007500639A patent/JP4966186B2/ja not_active Expired - Fee Related
- 2006-01-30 CA CA002596060A patent/CA2596060A1/en not_active Abandoned
- 2006-01-30 CN CN2006800036007A patent/CN101111509B/zh not_active Expired - Fee Related
- 2006-01-30 WO PCT/JP2006/301483 patent/WO2006080509A1/ja active Application Filing
-
2007
- 2007-07-20 NO NO20073787A patent/NO20073787L/no not_active Application Discontinuation
- 2007-07-23 IL IL184779A patent/IL184779A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006080509A1 (ja) | 2006-08-03 |
| BRPI0607287A2 (pt) | 2009-08-25 |
| US7825103B2 (en) | 2010-11-02 |
| CN101111509A (zh) | 2008-01-23 |
| EP1845102A1 (en) | 2007-10-17 |
| EP1845102A4 (en) | 2012-07-04 |
| TW200637870A (en) | 2006-11-01 |
| JP4966186B2 (ja) | 2012-07-04 |
| RU2395517C2 (ru) | 2010-07-27 |
| MY142304A (en) | 2010-11-15 |
| KR20070103012A (ko) | 2007-10-22 |
| IL184779A0 (en) | 2007-12-03 |
| AU2006209422B2 (en) | 2010-08-12 |
| JPWO2006080509A1 (ja) | 2008-06-19 |
| CA2596060A1 (en) | 2006-08-03 |
| NZ560252A (en) | 2009-10-30 |
| US20090118222A1 (en) | 2009-05-07 |
| CN101111509B (zh) | 2011-02-16 |
| RU2007132737A (ru) | 2009-03-10 |
| AU2006209422A1 (en) | 2006-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20073787L (no) | Nye pyrimidin-nukleosidforbindelser eller dets salt | |
| DOP2011000061A (es) | Compuestos de pirrol | |
| CO5700768A2 (es) | Derivados de benzoxazina y sus usos | |
| NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
| NZ595260A (en) | 1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof | |
| BRPI0506927A (pt) | compostos orgánicos | |
| MX2009008465A (es) | Nuevas 2-aminooxazolinas como ligandos de taar1. | |
| NO20090760L (no) | Nye tricykliske spiropiperidinforbindelser, deres synteser og deres anvendelser som modulatorer av kemokinreseptor-aktivitet | |
| NO20065830L (no) | Substituerte 2-kinolyloksazoler som er anvendbare som PDE4-inhibitorer. | |
| TW200745034A (en) | New compounds | |
| EP1795536A4 (en) | PHOSPHORAMIDITE COMPOUND AND PROCESS FOR THE PREPARATION OF OLIGO RNA | |
| MX2010004893A (es) | Compuesto heterociclico y composicion farmaceutica del mismo. | |
| MX2009012380A (es) | Compuestos de heteroarilamida pirimidona. | |
| MY148980A (en) | Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics | |
| CY1115635T1 (el) | Παραγωγα 2-πυριδιν-2-υλο-πυραζολ-3(2η)-ονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| RS51190B (sr) | Aminoacilni derivati kao prolekovi i lekovi za lečenje tromboembolijskih bolesti | |
| CY1111748T1 (el) | Παραγωγα 7-αλκυνυλο-1.8-ναφθυριδονων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη | |
| EA201171012A1 (ru) | Производные 5-фторбензотиазолов и 5-фторбензимидазолов, содержащие 6-замещенный триазолопиридазинсульфанил в положении 6: получение, применение в качестве лекарственных средств и применение в качестве ингибиторов met | |
| HUP0201357A2 (hu) | Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával | |
| TNSN07439A1 (en) | Derivatives of,4,5 - diarylpyrrole, preparation method thereof and use of same in therapeutics | |
| EA200300458A1 (ru) | Новые соединения аминотриазолона, способ их получения и фармацевтические композиции, содержащие их | |
| HK1130496A1 (en) | 3'-ethynylcytidine derivative 3'- | |
| NO20065323L (no) | 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav | |
| EA201000084A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |